139 related articles for article (PubMed ID: 23237390)
1. [Adherence of patients with stable angina to treatment with trimetazidine MR and frequency of emergency medical care: results of the EFFECT study].
Glezer MG; Saĭgitov RT
Kardiologiia; 2012; 52(11):4-11. PubMed ID: 23237390
[TBL] [Abstract][Full Text] [Related]
2. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Sellier P; Broustet JP
Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
[TBL] [Abstract][Full Text] [Related]
3. Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice.
Glezer MG; Vygodin VA;
Adv Ther; 2018 Sep; 35(9):1368-1377. PubMed ID: 30105656
[TBL] [Abstract][Full Text] [Related]
4. [Trimetazidine addition to antianginal therapy: effects on efficacy and quality of life in patients with stable angina treated outpatiently].
Ter Arkh; 2012; 84(4):38-41. PubMed ID: 22774489
[TBL] [Abstract][Full Text] [Related]
5. Treatment of stable angina pectoris with trimetazidine modified release in Indian primary-care practice.
Gupta R; Sawhney JP; Narain VS
Am J Cardiovasc Drugs; 2005; 5(5):325-9. PubMed ID: 16156688
[TBL] [Abstract][Full Text] [Related]
6. The Effectiveness of Trimetazidine Treatment in Patients with Stable Angina Pectoris of Various Durations: Results from the CHOICE-2 Study.
Glezer M;
Adv Ther; 2018 Jul; 35(7):1103-1113. PubMed ID: 29766461
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of trimetazidine prolong in stable coronary artery disease. Multicenter, prospective, observational study, ONECAPS study].
Tomcsányi J; Szakács L
Orv Hetil; 2018 Sep; 159(38):1549-1555. PubMed ID: 30227735
[TBL] [Abstract][Full Text] [Related]
8. [Thiotriazoline in the Treatment of Stable Angina Pectoris of II-III Functional Class].
Kadin DV; Chumak BA; Filippov AE; Shustov SB
Kardiologiia; 2015; 55(8):26-9. PubMed ID: 26761968
[TBL] [Abstract][Full Text] [Related]
9. [The (PRIMA) Study. Comparison of clinical effect of trimetazidine MR in men and women].
Vasiuk IuA; Shal'nova SA; Shkol'nik EL; Kulikov KG
Kardiologiia; 2011; 51(6):11-5. PubMed ID: 21878064
[TBL] [Abstract][Full Text] [Related]
10. [Triple antianginal combinations in the treatment of elderly and senile patients with stable angina].
Kanorskii SG; Smolenskaya NV
Ter Arkh; 2016; 88(12):33-40. PubMed ID: 28139557
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the efficiency of combined pharmacotherapy with the use of trimetazidine with prolonged release in patients with stable angina in outpatient practice].
Luneva YV; Povetkin SV
Ter Arkh; 2019 Aug; 91(8):18-21. PubMed ID: 32598749
[TBL] [Abstract][Full Text] [Related]
12. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis.
Danchin N; Marzilli M; Parkhomenko A; Ribeiro JP
Cardiology; 2011; 120(2):59-72. PubMed ID: 22122948
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the antianginal effectiveness of trimetazidine in a new dosage form for a single dose, depending on the region of the Russian Federation. ODA trial results].
Glezer MG; Vygodin VA
Kardiologiia; 2019 Sep; 59(10S):52-63. PubMed ID: 31876462
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes.
Meiszterics Z; Kónyi A; Hild G; Sárszegi Z; Gaszner B
J Comp Eff Res; 2017 Nov; 6(8):649-657. PubMed ID: 29148291
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
Szwed H; Sadowski Z; Elikowski W; Koronkiewicz A; Mamcarz A; Orszulak W; Skibińska E; Szymczak K; Swiatek J; Winter M
Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
Szwed H; Pachocki R; Domzal-Bochenska M; Szymczak K; Szydlowski Z; Paradowski A; Gajos G; Kaluza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
Presse Med; 2000 Mar; 29(10):533-8. PubMed ID: 10761517
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of antianginal and antiischemic effect of trimetazidine and its effects on myocardial perfusion in patients with ischemic heart disease and stable angina.].
Orlova EM; Mironova IIu; Matveeva MA; Lupanov VP; Samoĭlenko LE; Naumov VG
Kardiologiia; 2004; 44(9):23-8. PubMed ID: 15477771
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
Ruzyllo W; Szwed H; Sadowski Z; Elikowski W; Grzelak-Szafranska H; Orszulak W; Szymczak K; Winter M
Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
[TBL] [Abstract][Full Text] [Related]
19. Real-world Evidence for the Antianginal Efficacy of Trimetazidine from the Russian Observational CHOICE-2 Study.
Glezer M;
Adv Ther; 2017 Apr; 34(4):915-924. PubMed ID: 28220388
[TBL] [Abstract][Full Text] [Related]
20. [Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)].
Chaloupka V
Vnitr Lek; 2006 Jun; 52(6):609-14. PubMed ID: 16871765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
